|
|
|
Insider
Information: |
Santini Gino |
Relationship: |
Director |
City: |
Indianapolis |
State: |
IN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
172,151 |
|
Indirect Shares
|
3,249 |
|
|
Direct
Value |
$82,659,733 |
|
|
Indirect Value
|
$2,702,388 |
|
|
Total
Shares |
175,400 |
|
|
Total
Value |
$85,362,121 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eli Lilly & Co |
LLY |
Sr.VP, Corp. Strategy ... |
2009-12-07 |
96,495 |
2009-12-07 |
3,249 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
Director |
2020-11-16 |
0 |
2013-05-23 |
0 |
Premium* |
|
Collegium Pharmaceutical, Inc |
COLL |
Director |
2024-05-16 |
75,656 |
|
0 |
Premium* |
|
Horizon Pharma, Inc. |
HZNP |
Director |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
83 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LLY |
Eli Lilly & Co |
President, US Operations |
|
2005-01-14 |
4 |
A |
$56.79 |
$318,024 |
D/D |
5,600 |
81,452 |
|
- |
|
LLY |
Eli Lilly & Co |
officerTitle |
|
2006-01-20 |
4 |
A |
$57.04 |
$358,725 |
D/D |
6,289 |
87,334 |
|
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2007-01-17 |
4 |
A |
$52.86 |
$1,058,522 |
D/D |
20,025 |
99,467 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2008-01-25 |
4 |
A |
$50.74 |
$1,192,897 |
D/D |
23,510 |
118,715 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Director |
|
2013-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,300 |
5,075 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Director |
|
2014-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,800 |
8,875 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Director |
|
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,322 |
10,197 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Director |
|
2016-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,768 |
14,965 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Director |
|
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,545 |
19,510 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2018-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,253 |
25,441 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Director |
|
2018-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,578 |
23,088 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2019-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,707 |
30,148 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Director |
|
2019-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,116 |
31,204 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,047 |
34,195 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Director |
|
2020-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,269 |
41,473 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
9,941 |
44,136 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
14,035 |
58,171 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,792 |
67,963 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2024-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,693 |
75,656 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President, US Operations |
|
2004-03-11 |
4 |
D |
$70.49 |
$480,460 |
D/D |
(6,816) |
59,852 |
|
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2005-10-07 |
4 |
D |
$54.01 |
$910,879 |
D/D |
(16,865) |
86,045 |
|
- |
|
LLY |
Eli Lilly & Co |
officerTitle |
|
2006-02-01 |
4 |
D |
$56.62 |
$100,670 |
D/D |
(1,778) |
85,556 |
|
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2006-02-23 |
4 |
D |
$56.10 |
$540,580 |
D/D |
(9,636) |
89,030 |
|
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2006-06-23 |
4 |
D |
$54.30 |
$83,785 |
D/D |
(1,543) |
87,487 |
|
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2007-02-01 |
4 |
D |
$54.12 |
$108,078 |
D/D |
(1,997) |
97,470 |
0 |
- |
|
83 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|